GVOKE
Live / Registered — Registered (as of 24 Mar 2020)
What this means for you
Registered since 24 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88011935
- Registration number
- 6019623
- Mark type
- Stylized text
- Filed
- 22 Jun 2018
- Published for opposition
- 20 Nov 2018
- Registered
- 24 Mar 2020
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
Owner
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
- Xeris Pharmaceuticals, Inc., Chicago, IL, US
Prosecution history
- 18 Feb 2026 — TEAS SECTION 8 & 15 RECEIVED
- 24 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jun 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 May 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 May 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 May 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 May 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 20 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Feb 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Feb 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED